Improvement in Right Ventricular Dysfunction by Echocardiography After Percutaneous Large-Bore Thromboaspiration for Patients with High- and Intermediate-High Risk Acute Pulmonary Embolism

Sunday, March 5, 2023

3:00 PM – 3:09 PM

Location: Phoenix Convention Center, 221C

Presenting Author(s)

Haley Zarrin, BA

Medical Student
Icahn School of Medicine at Mount Sinai

Disclosure(s): No financial relationships to disclose

Author/Co-author(s)

JW

Jennifer M. Watchmaker, MD, PhD

Resident Physician
Mount Sinai Hospital
Vivian L. Bishay, MD

IR
Mount Sinai
RP

Rajesh I. Patel, MD

Assistant Professor, Diagnostic, Molecular and Interventional Radiology
Mount Sinai Hospital
F Scott Nowakowski, MD

Professor of Radiology and Surgery
Mount Sinai Medical System
Dan Shilo, MD

Assistant Professor, Diagnostic, Molecular and Interventional Radiology
Mount Sinai Hospital
Kirema Garcia-Reyes, MD (she/her/hers)

Assistant Professor
Icahn School of Medicine at Mount Sinai
RP

Rahul S. Patel, MD

Assistant Professor, Diagnostic, Molecular and Interventional Radiology
Mount Sinai Medical Center\n
AF

Aaron M. Fischman, MD, FSIR, FCIRSE, FSVM

Professor, Diagnostic, Molecular and Interventional Radiology
Icahn School of Medicine at Mount Sinai
Robert A. Lookstein, MD

Executive Vice Chair; Diagnostic, Molecular, and Interventional Radiology
Icahn School of Medicine at Mount Sinai

Disclosure(s):

Haley Zarrin, BA: No financial relationships to disclose

F Scott Nowakowski, MD: No financial relationships to disclose

Kirema Garcia-Reyes, MD: No financial relationships to disclose

Robert A. Lookstein, MD: No relevant disclosure to display

Purpose:

Right ventricular dysfunction (RVD) predicts outcomes in patients with acute pulmonary embolism (PE). Therefore, our goal was to evaluate changes in RVD before and after large bore thromboaspiration using the FlowTriever System (Inari Medical, Irvine, California) in patients presenting with high risk (HR) and high-intermediate risk (HIR) acute PE.

Materials and Methods:

Patients treated between January 2019 and July 2022 were retrospectively reviewed. Pre- and post-procedural pulmonary artery systolic pressure (PASP; from catheter measurements), RV systolic pressure (RVSP; from echo), RV dilation, length of stay (LOS), and 30-day mortality were recorded.

Results:

74 patients underwent intervention, 18 (24.3%) of which had HR and 56 (75.7%) HIR PE. 37 patients (17 female; median age 60, range 27-86) had formal pre- and post-thromboaspiration echos within 90 days. Median days to post-procedure echo was 2.0 (range 1-89d, IQR [2.0-4.0]). 34 patients (87.2%) had RV dilation on pre-procedural echo and 20 (51.3%) following intervention (p < 0.01). 20 patients (54.1%) had severely decreased RV function pre-procedurally, compared to 4 (10.8%) after (p < 0.01). 19 patients (48.7%) had elevated RVSP pre-, which decreased to 8 (23.5%) post-procedurally (p < 0.01). PASP decreased an average of 16.2mmHg (45.9 pre-, 29.7 post-procedurally, p< 0.01). Fewer patients had hypokinesis (18 (48.7%) pre-; 6 (16.2%) post-procedurally, p< 0.01) and McConnell’s sign (11 (29.7%) pre-; 1 (2.7%) post-procedurally, p< 0.01) after thromboaspiration. Median LOS was 9.0d (IQR [4.0-28.0]) and 30d survival rate was 97.3% (1 patient with HIR PE died).

Conclusion:

Treatment of HR and HIR PE with large bore thromboaspiration results in improved RV function. Ongoing multidisciplinary research will help define long term cardiac outcomes.